The aim of this ConcepTT project is to develop and benchmark a prototype reactor which allows the execution of electrophotocatalytic chemistry in continuous flow, thereby significantly improving its applicability, performance and scalability for use in pharmaceutical production. From these technological advances, the project will attempt to establish a strong IP positon and to create additional visibility of and traction for this technology in the industry.